N85.00
Endometrial hyperplasia, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Hyperplasia (adenomatous) (cystic) (glandular) of endometrium
- Hyperplastic endometritis
Medical Intelligence & Overview
Endometrial hyperplasia, classified under ICD-10 code N85.00, is a condition characterized by the thickening of the lining of the uterus, known as the endometrium. This overgrowth occurs due to an increase in the number of endometrial glands and cells, often resulting from hormonal imbalances. The condition can range from mild to severe and may sometimes lead to changes in the uterine lining that are precancerous. Recognizing the symptoms and causes of endometrial hyperplasia is important for timely diagnosis and management.
Causes & Symptoms
Clinical Causes: Excess estrogen without sufficient progesterone, often seen in unopposed estrogen therapy Hormonal imbalances related to polycystic ovary syndrome (PCOS) Obesity, which can increase estrogen levels due to fat tissue conversion Perimenopause or menopause, associated with fluctuating hormone levels Ovarian tumors that produce estrogen Tamoxifen therapy for breast cancer patients Irregular menstrual cycles leading to prolonged estrogen exposure Certain rare genetic or endocrine disorders
Key Symptoms: Abnormal uterine bleeding, such as heavier or irregular periods Spotting between periods Postmenopausal bleeding Pelvic discomfort or pressure Unusual vaginal discharge There may be no noticeable symptoms in early stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and specialized testing. The typical process includes: - Medical history review and physical examination - Transvaginal ultrasound to assess endometrial thickness - Endometrial biopsy, where a tissue sample is taken from the lining for microscopic examination - Hysteroscopy, a procedure that allows direct visualization of the uterine cavity Pathological examination of biopsy samples helps determine whether hyperplasia is simple, complex, with or without atypia, which influences treatment options.
Treatment Protocols: Treatment strategies depend on the severity of hyperplasia and the presence of atypia. Common approaches include: - Monitoring for mild hyperplasia without atypia, often with regular follow-up ultrasounds and biopsies - Hormonal therapy with progestins to counteract estrogen effects and promote normalization of the endometrial lining - Removal of abnormal tissue via hysteroscopic procedures if indicated - Surgical options, such as hysterectomy, for severe cases or when atypia is present - Addressing underlying causes like obesity or hormone imbalance through lifestyle changes and medical management Close follow-up is essential to ensure the condition does not progress to more severe disease, such as endometrial cancer.
Clinical Advice & FAQs
Billing Guidance
Is N85.00 a billable ICD-10 code?
Yes, N85.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N85.00?
Clinical documentation must specify the nature of Endometrial hyperplasia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference